BeiGene Ltd (BEIGF)
14.40
0.00 (0.00%)
USD |
OTCM |
Dec 17, 16:00
BeiGene Total Liabilities (Quarterly): 2.395B for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Theravance Biopharma Inc | 170.45M |
| CEL-SCI Corp | 15.60M |
| AIM ImmunoTech Inc | 10.68M |
| IGC Pharma Inc | 2.992M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 5.831B |
| Shareholders Equity (Quarterly) | 3.436B |
| Debt to Equity Ratio | 0.306 |
| Current Ratio | 1.931 |
| Net Debt Paydown Yield | -0.40% |